I-Corps Deadlines and Dates for FY 2024 Cohorts Announced
The I-Corps at NIH program helps researchers and technologists translate products from the lab into the marketplace by providing project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with small business funding. NIH recently appended the notice of funding opportunity with key dates for the next cycle of awardees.
| Cohort 1 | Cohort 2 | |
|---|---|---|
| Application Due Date | November 15, 2023 | January 31, 2024 |
| Phone Interview | January 9 and 10, 2024 | March 11 and 12, 2024 |
| Kick-off Venue | TBD (in person) | TBD (in person) |
| Course Kick-off | March 4 to 7, 2024 | May 6 to 9, 2024 |
| Webinars (Virtual) | March 13, 20, 27 April 3, 10, 17, 2024 | May 15, 22, 29 June 5, 12, 18, 2024 |
| Close-out Venue | Bethesda, MD (in person) | Bethesda, MD (in person) |
| Course Close-out | April 22 and 23, 2024 | June 24 and 25, 2024 |
| Cohort Size | 24 Teams | 24 Teams |
Refer to Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp, Clinical Trial NOT Allowed) for further explanation.
Materials from CHIVIM Clinical Studies and Trials Available
NIAID has current Good Manufacturing Practices (cGMP) material for use in controlled human influenza virus infection model (CHIVIM) clinical studies and trials, with limited availability. The Institute produced RG-A/Texas/71/2017 (H3N2; clade 3c3a) cGMP material and is currently funding the production of an H1N1 challenge strain.
Investigators may request access by submitting a protocol synopsis that summarizes the clinical trial/study design and endpoints, route of administration, age groups, and inclusion/exclusion criteria. Email NIAIDCHIVIMreagentrequests@mail.nih.gov to indicate your interest and initiate the process. NIAID will evaluate requests for access twice a year, with request forms and materials due annually by March 15 and October 15.
Refer to the September 15, 2023 Guide notice for complete details.
Small Business Collaboration with Resource-Limited Institutions
As explained in Notice of Special Interest: Encouraging Small Businesses to Partner with Resource-Limited Institutions (RLIs) on Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Applications, NIH views collaborations between small businesses and resource limited institutions as mutually beneficial and underutilized. Read the notice linked above if your organization is interested in exploring such a partnership.